FERREIRA SANTOS WELDER sold $55K of AFYA

FERREIRA SANTOS WELDER (Controller) sold 4,161 shares of Afya Ltd (AFYA) at $13.30 on 2026-10-05.

Original reporting
SEC EDGAR · FERREIRA SANTOS WELDER
Published Oct 6, 2026, 8:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFYA
Neutral
high confidence
Mentioned
$AFYA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFYANeutralLow
01

Why it matters

The transaction is a routine insider sell with limited material impact on price, but it provides transparency for shareholders.

02

Market read

A small insider sell that is unlikely to move the stock significantly but adds to the flow of insider activity data.

03

What to watch

The insider's remaining 35,000 shares still represent a sizable stake, suggesting continued confidence despite the modest sale.

Relevance 3/10Novelty 3/10Timing: today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$AFYANeutralHigh confidence
Context

Officer sold 4,161 shares for $55,341, reducing holdings to 35,000 shares.

Expected impact

potential slight downward pressure as the market prices the insider sell.

Evidence & confidence

A $55k sale by a controller is a primary filing but the amount is small relative to market cap, limiting material impact.

Market effects

Minimal impact on the healthcare services sector; the sale is too small to affect sector sentiment.

No notable regional effect; the filing is specific to Afya.

Low global relevance; only investors tracking Afya may note the transaction.

Counterpoint

The sale could be interpreted as a signal that the insider expects near‑term weakness, presenting a buying opportunity if the market overreacts.

Key entities

  • Afya Ltd

    US‑listed healthcare services provider (ticker AFYA).

  • FERREIRA SANTOS WELDER

    Controller and officer of Afya Ltd who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFYAMed

Afya Limited (AFYA) Q3 Revenue Rises 6.1% to R$985.2M

Afya Limited reported Q3 2026 revenue of R$985.2M, up 6.1% YoY, and Adjusted EBITDA of R$433.8M, up 8.7%. Nine-month net income rose 6.9% to R$634.0M. The company reaffirmed its full-year 2026 guidance. The next catalysts are shareholder and regulatory decisions on its proposed merger with Yduqs.

$AFYAHigh

Afya Ltd (AFYA): Financial results for Q3 2026

Afya Ltd (AFYA) furnished an SEC Form 6-K — earnings release. Afya Limited Announces Third Quarter and Nine Months 2026 Financial Results Strong Cash Conversion and Continued Earnings Growth Full-Year 2026 Guidance Reaffirmed Belo Horizonte, Brazil, November 12, 2026 – Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the l

$AFYAHigh

BofA upgrades Afya stock rating on exam rule changes

BofA upgraded Afya (AFYA) to Buy, lowering its price target to $16. The firm cited Afya's resilient student base, low leverage, and recent exam rule changes as reasons. Afya trades at $10.24, near its 52-week low, with a 6.32 P/E ratio and 30% free cash flow yield. Afya reported 6% Q2 and 7% H1 revenue growth, with net income rising 14% and 7% respectively. JPMorgan also upgraded Afya to Overweight, expecting merger synergies.